🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Giovanna Rossi

University of Milan

ORCID: 0000-0002-4995-5161
Social SciencesMedicineBiochemistry, Genetics and Molecular BiologyBusiness, Management and Accounting

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.430Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United States

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae327
Top 43%
0.430DataRank
Top 43%8 citations

Rachael Adcock, William C. Hunt, Michael J. Robertson, Norah Torrez‐Martinez, Ruth McDonald +22 more

Papers

Driven by 5 papers — median percentile 57. Top paper: “Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United States”.

Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United States

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae327
Top 43%
0.430DataRank
Top 43%8 citations

Rachael Adcock, William C. Hunt, Michael J. Robertson, Norah Torrez‐Martinez, Ruth McDonald +22 more

A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.08.033
N/A
0DataRank · unranked
14 citations

Christopher Mathews, Michael Robertson, Charles L. Wiggins, Yolanda J. McDonald, Daniel W. Goldberg +17 more

Adherence to National Guidelines on Cervical Screening: A Population-Based Evaluation From a Statewide Registry

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab173
N/A
0DataRank · unranked
10 citations

Walter Kinney, Lu Chen, Jane J. Kim, Steven Jenison, Giovanna Rossi +23 more

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.159
N/A
0DataRank · unranked
450 citations

Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross +93 more

Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States

American Journal of Obstetrics and Gynecology(2023)10.1016/j.ajog.2023.09.100
N/A
0DataRank · unranked
4 citations

Norah Torrez‐Martinez, Edith Torres-Chavolla, Valentin Parvu, Jeffrey C Andrews, Ruofei Du +20 more